Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design
- PMID: 29387066
- PMCID: PMC5776009
- DOI: 10.3389/fimmu.2017.02009
Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design
Abstract
Hypotheses and theories are essential constituents of the scientific method. Many vaccinologists are unaware that the problems they try to solve are mostly inverse problems that consist in imagining what could bring about a desired outcome. An inverse problem starts with the result and tries to guess what are the multiple causes that could have produced it. Compared to the usual direct scientific problems that start with the causes and derive or calculate the results using deductive reasoning and known mechanisms, solving an inverse problem uses a less reliable inductive approach and requires the development of a theoretical model that may have different solutions or none at all. Unsuccessful attempts to solve inverse problems in HIV vaccinology by reductionist methods, systems biology and structure-based reverse vaccinology are described. The popular strategy known as rational vaccine design is unable to solve the multiple inverse problems faced by HIV vaccine developers. The term "rational" is derived from "rational drug design" which uses the 3D structure of a biological target for designing molecules that will selectively bind to it and inhibit its biological activity. In vaccine design, however, the word "rational" simply means that the investigator is concentrating on parts of the system for which molecular information is available. The economist and Nobel laureate Herbert Simon introduced the concept of "bounded rationality" to explain why the complexity of the world economic system makes it impossible, for instance, to predict an event like the financial crash of 2007-2008. Humans always operate under unavoidable constraints such as insufficient information, a limited capacity to process huge amounts of data and a limited amount of time available to reach a decision. Such limitations always prevent us from achieving the complete understanding and optimization of a complex system that would be needed to achieve a truly rational design process. This is why the complexity of the human immune system prevents us from rationally designing an HIV vaccine by solving inverse problems.
Keywords: antibody affinity maturation; bounded rationality; inverse problems; rational vaccine design; reductionism; reverse vaccinology; transmitted founder virus; virus inactivation.
Similar articles
-
Basic research in HIV vaccinology is hampered by reductionist thinking.Front Immunol. 2012 Jul 9;3:194. doi: 10.3389/fimmu.2012.00194. eCollection 2012. Front Immunol. 2012. PMID: 22787464 Free PMC article.
-
Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?AIMS Public Health. 2015 May 6;2(2):183-193. doi: 10.3934/publichealth.2015.2.183. eCollection 2015. AIMS Public Health. 2015. PMID: 29546103 Free PMC article. Review.
-
An Outdated Notion of Antibody Specificity is One of the Major Detrimental Assumptions of the Structure-Based Reverse Vaccinology Paradigm, Which Prevented It from Helping to Develop an Effective HIV-1 Vaccine.Front Immunol. 2014 Nov 18;5:593. doi: 10.3389/fimmu.2014.00593. eCollection 2014. Front Immunol. 2014. PMID: 25477882 Free PMC article. Review.
-
Design in biology and rational design in vaccinology: A conceptual analysis.Methods. 2021 Nov;195:120-127. doi: 10.1016/j.ymeth.2021.07.010. Epub 2021 Aug 2. Methods. 2021. PMID: 34352372 Review.
-
The Human Immune Response to HIV and its Impact in the Potential Development of an Inactivated HIV Vaccine.AIDS Rev. 2016 Jul-Sep;18(3):151-157. AIDS Rev. 2016. PMID: 27438575 Review.
Cited by
-
Geo-temporal patterns to design cost-effective interventions for zoonotic diseases -the case of brucellosis in the country of Georgia.Front Vet Sci. 2023 Dec 20;10:1270505. doi: 10.3389/fvets.2023.1270505. eCollection 2023. Front Vet Sci. 2023. PMID: 38179332 Free PMC article.
-
Quantum vaccinomics platforms to advance in vaccinology.Front Immunol. 2023 Jun 15;14:1172734. doi: 10.3389/fimmu.2023.1172734. eCollection 2023. Front Immunol. 2023. PMID: 37398646 Free PMC article.
-
Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data.Front Immunol. 2019 Jun 12;10:1258. doi: 10.3389/fimmu.2019.01258. eCollection 2019. Front Immunol. 2019. PMID: 31249569 Free PMC article.
-
Review of preventative HIV vaccine clinical trials in South Africa.Arch Virol. 2020 Nov;165(11):2439-2452. doi: 10.1007/s00705-020-04777-2. Epub 2020 Aug 14. Arch Virol. 2020. PMID: 32797338 Free PMC article. Review.
-
What does it mean to develop an HIV vaccine by rational design?Arch Virol. 2021 Jan;166(1):27-33. doi: 10.1007/s00705-020-04884-0. Epub 2020 Nov 29. Arch Virol. 2021. PMID: 33251565 Review.
References
-
- Chalmers AF. What Is This Thing Called Science. Maidenhead, UK: Open University Press, Mc Graw-Hill House; (1999). p. 1–226.
-
- Bauer HH. Scientific Literacy and the Myth of the Scientific Method. Urbana, Chicago, US: University of Illinois Press; (1992). p. 1–180.
-
- Stokes DE. Pasteur’s Quadrant. Basic Science and Technological Innovation. Washington, DC, USA: Brooking Institution Press; (1997). p. 1–196.
-
- Gauch HG. Scientific Method in Brief. Cambridge, UK: Cambridge Univ Press; (2012). p. 1–288.
LinkOut - more resources
Full Text Sources
Other Literature Sources